Pacira Pharmaceuticals (PCRX) PT Lowered to $45 at RBC Capital

March 1, 2024 7:26 AM EST Send to a Friend

RBC Capital analyst Daniel Busb ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Pacira Pharmaceuticals (PCRX) PT Lowered to $45 at RBC Capital

Member Login

Free News Feed